GN Store Nord A/S (GNNDY)
OTCMKTS · Delayed Price · Currency is USD
52.80
-1.51 (-2.78%)
Oct 13, 2025, 3:26 PM EDT
GN Store Nord Market Cap
GN Store Nord has a market cap or net worth of $2.56 billion as of October 13, 2025. Its market cap has decreased by -24.87% in one year.
Market Cap
2.56B
Enterprise Value
4.21B
Revenue
2.73B
Ranking
n/a
PE Ratio
18.57
Stock Price
$52.80
Market Cap Chart
Since March 30, 1993, GN Store Nord's market cap has increased from 53.13M to 2.56B, an increase of 4,709.37%. That is a compound annual growth rate of 12.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 2.66B | -1.84% |
| Dec 30, 2024 | 2.71B | -26.91% |
| Dec 29, 2023 | 3.71B | 26.26% |
| Dec 30, 2022 | 2.94B | -63.28% |
| Dec 30, 2021 | 8.00B | -22.82% |
| Dec 30, 2020 | 10.36B | 70.78% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 671.65M |
| Glass House Brands | 650.22M |
| Veradigm | 525.44M |
| Northwest Biotherapeutics | 378.75M |
| CytoDyn | 335.98M |
| Nika Pharmaceuticals | 333.67M |
| American Oncology Network | 283.44M |
| Silence Therapeutics | 236.17M |